NFKB1 and colitis: Recently, LN successfully lowered pro-inflammatory cytokines IL-6 and NF-κB and attenuated the macroscopic as well as the histological changes in trinitrobenzene sulfonic acid-evoked colitis; an experimental model of IBD in rats (Arab et al. 2021).